Attilio Olivieri

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study

Francesco Passamonti, Chiara Cattaneo, Luca Arcaini et al. · The Lancet Haematology · 2020 · 554 citations · Full text

Medicine, Hematology, Oncology +16

Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2014 Response Criteria Working Group Report

Stephanie J. Lee, Daniel Wolff, Carrie L. Kitko et al. · Biology of Blood and Marrow Transplantation · 2015 · 419 citations · Full text

Life Sciences, Immunology, Immunotherapy +12

Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage

Marco Ladetto, Federica De Marco, Fabio Benedetti et al. · Blood · 2008 · 253 citations · Full text

Medicine, Immunology, Oncology +11

Imatinib for refractory chronic graft-versus-host disease with fibrotic features

Attilio Olivieri, Franco Locatelli, Marco Zecca et al. · Blood · 2009 · 233 citations

Life Sciences, Immunology, Internal Medicine +14

Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease

Silvia Svegliati, Attilio Olivieri, Nadia Campelli et al. · Blood · 2007 · 216 citations · Full text

Life Sciences, Immunology, Pathology +14